{"id":"https://openalex.org/W2170100593","doi":"https://doi.org/10.1086/339326","title":"Valacyclovir for Episodic Treatment of Genital Herpes: A Shorter 3\u2010Day Treatment Course Compared with 5\u2010Day Treatment","display_name":"Valacyclovir for Episodic Treatment of Genital Herpes: A Shorter 3\u2010Day Treatment Course Compared with 5\u2010Day Treatment","alternate_titles":[],"publication_year":2002,"publication_date":"2002-04-01","ids":{"openalex":"https://openalex.org/W2170100593","doi":"https://doi.org/10.1086/339326","mag":"2170100593","pmid":"https://pubmed.ncbi.nlm.nih.gov/11880962"},"language":"en","primary_location":{"id":"doi:10.1086/339326","doi":"https://doi.org/10.1086/339326","is_oa":false,"landing_page_url":"https://doi.org/10.1086/339326","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2170100593"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112868388","display_name":"Peter A. Leone","orcid":"https://orcid.org/0009-0003-6012-091X","observed_orcids":["https://orcid.org/0009-0003-6012-091X"]},"institutions":[{"id":"https://openalex.org/I114027177","display_name":"University of North Carolina at Chapel Hill","ror":"https://ror.org/0130frc33","country_code":"US","type":"education","lineage":["https://openalex.org/I114027177"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Peter A. Leone","raw_affiliation_strings":["Department of Infectious Diseases, University of North Carolina, Chapel Hill, NC, 27599, USA. pal007@med.unc.edu","Department of Infectious Diseases University of North Carolina, Chapel Hill"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Infectious Diseases, University of North Carolina, Chapel Hill, NC, 27599, USA. pal007@med.unc.edu","institution_ids":["https://openalex.org/I114027177"]},{"raw_affiliation_string":"Department of Infectious Diseases University of North Carolina, Chapel Hill","institution_ids":["https://openalex.org/I114027177"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070026019","display_name":"Sylvie Trottier","orcid":"https://orcid.org/0000-0002-3986-5146","observed_orcids":["https://orcid.org/0000-0002-3986-5146"]},"institutions":[{"id":"https://openalex.org/I43406934","display_name":"Universit\u00e9 Laval","ror":"https://ror.org/04sjchr03","country_code":"CA","type":"education","lineage":["https://openalex.org/I43406934"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"Sylvie Trottier","raw_affiliation_strings":["Centre de Recherche Infectiologie Universite Laval, Sainte Foy, Quebec, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre de Recherche Infectiologie Universite Laval, Sainte Foy, Quebec, Canada","institution_ids":["https://openalex.org/I43406934"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5105285968","display_name":"J. Mitchell Miller","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Mitchell Miller","raw_affiliation_strings":["GlaxoSmithKline, Research Triangle Park, North Carolina"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"GlaxoSmithKline, Research Triangle Park, North Carolina","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5112868388"],"corresponding_institution_ids":["https://openalex.org/I114027177"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":null,"fwci":5.4414,"has_fulltext":false,"cited_by_count":104,"citation_normalized_percentile":{"value":0.96080018,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"34","issue":"7","first_page":"958","last_page":"962"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10625","display_name":"Herpesvirus Infections and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10981","display_name":"Cytomegalovirus and herpesvirus research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11713","display_name":"Genital Health and Disease","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/valacyclovir","display_name":"valacyclovir","score":1.0},{"id":"https://openalex.org/keywords/recurrent-genital-herpes","display_name":"recurrent genital herpes","score":0.9340000152587891},{"id":"https://openalex.org/keywords/episodic-treatment","display_name":"episodic treatment","score":0.9039999842643738},{"id":"https://openalex.org/keywords/dosing-schedule-comparison","display_name":"dosing schedule comparison","score":0.6930000185966492},{"id":"https://openalex.org/keywords/lesion-healing-time","display_name":"lesion healing time","score":0.8679999709129333},{"id":"https://openalex.org/keywords/pain-duration","display_name":"pain duration","score":0.8519999980926514},{"id":"https://openalex.org/keywords/episode-length","display_name":"episode length","score":0.7710000276565552},{"id":"https://openalex.org/keywords/herpes-simplex-virus","display_name":"herpes simplex virus","score":0.4339999854564667}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9392609596252441},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.6852188110351562},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6740812659263611},{"id":"https://openalex.org/C3020807538","wikidata":"https://www.wikidata.org/wiki/Q65122171","display_name":"Day treatment","level":2,"score":0.5357709527015686},{"id":"https://openalex.org/C183021626","wikidata":"https://www.wikidata.org/wiki/Q4620674","display_name":"Sex organ","level":2,"score":0.5261321067810059},{"id":"https://openalex.org/C2778498788","wikidata":"https://www.wikidata.org/wiki/Q7476596","display_name":"Genital herpes","level":4,"score":0.4225258231163025},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.38847801089286804},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34879136085510254},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.08563411235809326},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.07542139291763306},{"id":"https://openalex.org/C2781196997","wikidata":"https://www.wikidata.org/wiki/Q655331","display_name":"Herpes simplex virus","level":3,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077483","descriptor_name":"Valacyclovir","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D000212","descriptor_name":"Acyclovir","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000998","descriptor_name":"Antiviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006558","descriptor_name":"Herpes Genitalis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":true},{"descriptor_ui":"D014633","descriptor_name":"Valine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1086/339326","doi":"https://doi.org/10.1086/339326","is_oa":false,"landing_page_url":"https://doi.org/10.1086/339326","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:11880962","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11880962","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9940000176429749,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":8,"referenced_works":["https://openalex.org/W1988435701","https://openalex.org/W2094067428","https://openalex.org/W2094871865","https://openalex.org/W2112548512","https://openalex.org/W2155576328","https://openalex.org/W2327052210","https://openalex.org/W2334917064","https://openalex.org/W4255803264"],"related_works":["https://openalex.org/W2012654104","https://openalex.org/W2082468056","https://openalex.org/W2055385460","https://openalex.org/W4299901188","https://openalex.org/W2201702582","https://openalex.org/W2117567797","https://openalex.org/W2112548512","https://openalex.org/W2223948227","https://openalex.org/W1994608982"],"abstract_inverted_index":{"Valacyclovir":[0],"given":[1],"in":[2,117],"a":[3,29,39,145],"5-day":[4,40,85,119,146],"regimen":[5],"of":[6,17,19,28,38,45,52,66,76,80,108,127,130,138,153],"500":[7,128],"mg":[8,129],"twice":[9,133],"per":[10],"day":[11],"is":[12,142],"effective":[13],"as":[14,135],"short-term":[15],"treatment":[16,88,137],"episodes":[18],"recurrent":[20,139],"genital":[21,140],"herpes.":[22],"This":[23],"study":[24],"compared":[25],"the":[26,60,67,84,118],"efficacy":[27],"shorter,":[30],"3-day":[31,87,121,125],"course":[32,41,126,147],"(for":[33,42],"402":[34],"patients)":[35,44],"with":[36,49,110,148],"that":[37],"398":[43],"valacyclovir":[46,131],"for":[47,64,83],"persons":[48],"frequent":[50],"recurrence":[51],"symptoms.":[53],"No":[54],"significant":[55],"differences":[56],"were":[57,89,113],"detected":[58],"between":[59],"2":[61],"dosing":[62],"schedules":[63],"any":[65],"end":[68],"points":[69],"measured.":[70],"Median":[71],"times":[72],"to":[73,144,150],"lesion":[74],"healing,":[75],"pain":[77],"duration,":[78],"and":[79,99,115,120],"episode":[81],"length":[82],"versus":[86,91,96,102],"4.7":[90],"4.4":[92,100],"days,":[93,98,104],"2.5":[94],"days":[95,101],"2.9":[97],"4.3":[103],"respectively.":[105,123],"The":[106],"proportions":[107],"patients":[109],"aborted":[111],"lesions":[112],"26.6%":[114],"25.4%":[116],"groups,":[122],"A":[124],"administered":[132],"daily":[134],"episodic":[136],"herpes":[141],"equivalent":[143],"regard":[149],"key":[151],"markers":[152],"efficacy.":[154]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2170100593","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":5},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
